Investigating the impact of a comprehensive nurse support program on death anxiety and compliance with hormone therapy in women with breast cancer
Not Applicable
Recruiting
- Conditions
- Breast Cancer.Malignant neoplasm of breast
- Registration Number
- IRCT20240120060738N1
- Lead Sponsor
- Jahrom University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
Women with primary breast cancer
Completing the course of surgery, chemotherapy and radiotherapy
be under hormone therapy (any hormone medication) for at least one year
In the last six months, she did not undergo any intervention regarding medication compliance or anxiety reduction
Access to a mobile phone and the ability to use it
Ability to perform physical activity
Exclusion Criteria
Failure to respond to follow-up calls or unwillingness to continue studying
Discontinuation of medication due to side effects
Recurrence of the disease in one of the organs
Severe crisis in life
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adherence to drug treatment. Timepoint: Before and after the intervention. Method of measurement: Questionnaire of compliance with Moriski's drug treatment.;Anxiety. Timepoint: Before and after the intervention. Method of measurement: Templer Death Anxiety Questionnaire.
- Secondary Outcome Measures
Name Time Method